News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cadila Pharmaceuticals's Drug for Rheumatoid Arthritis Gets U.S. Okay



9/25/2007 6:29:32 AM

MUMBAI (Reuters) - Cadila Healthcare Ltd said on Tuesday it received approval from U.S. health regulators for its hydroxychloroquine sulphate tablets.

Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES